Use access key #2 to skip to page content.
$0.43 -0.03 (-6.30%)
8/29/2008 4:00 PM

Acusphere, Inc. (ACUS)

CAPS Rating:
****

A pharmaceutical company, which develops new drugs and improved formulations of existing drugs using its proprietary porous microparticle technology.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

ACUS doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

226 Outperforms
12 Underperforms
 

All-Stars

59 Outperforms
3 Underperforms
 

Members bullish on ACUS are also bullish on:

Members bearish on ACUS are also bearish on:

Ticker Tags

Small Cap (1922), Drug Manufacturers - Other (105), Biotechnology (294)
Suggest a tag

Acusphere, Inc. At A Glance

Current Price: $0.43
Last Trade Time: 8/29/2008 4:00 PM
Open: $0.46
Previous Close: $0.46
Daily Range: $0.43 - $0.46
52-Week Range: $0.31 - $1.73
Volume: 52,980
Market Cap: $1.07B
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ACUS VS S&P 500 (SPY)

ACUS 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for ACUS

More Headlines...

Top Bull Pitch

Recs

1

Acusphere, Inc. (ACUS)

Avatar foolishddaryl (25.04) Submitted: 5/22/08 3:05 PM

at todays proces a small investment here could earn back mega returns. There is plenty of risk, but Imagify looks like a solid product with plenty of applications.

They've submitted there application to the FDA and we should hear about the applications approval within the next month

From there we ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Acusphere, Inc. (ACUS)

Avatar zimn0016 (79.99) Submitted: 8/15/07 1:41 AM

needs a better pipeline

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 37 :   1 2 3 4 5 Next »

Show Pitch Replies

Recs

1

 (ACUS)

Avatar foolishddaryl (25.04) Submitted: 5/22/08 3:05 PM : Outperform Start Price: $3.47 ACUS Score: -80.87

at todays proces a small investment here could earn back mega returns. There is plenty of risk, but Imagify looks like a solid product with plenty of applications.

They've submitted there application to the FDA and we should hear about the applications approval within the next month

From there we are looking at Q1 2009 for an approval yay or nay.

It's a bit of a gamble but a small play here could pay big dividends. Just don't bet the farm. A little risk won't hurt, and the rewards could be exponetial

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ACUS)

Avatar leosshoes (49.40) Submitted: 10/08/07 11:20 AM : Outperform Start Price: $1.52 ACUS Score: -54.72

ACUS will get Imagify approved in January. It's price will rise significantly.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (ACUS)

Avatar harjac123 (< 20) Submitted: 10/02/07 7:57 AM : Outperform Start Price: $1.63 ACUS Score: -56.86

NDA will soon be submitted to FDA for "Imagify".

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ACUS)

Avatar zimn0016 (79.99) Submitted: 8/15/07 1:41 AM : Underperform Start Price: $1.70 ACUS Score: 64.89

needs a better pipeline

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (ACUS)

Avatar SavantTM (49.83) Submitted: 7/31/07 9:06 PM : Outperform Start Price: $1.63 ACUS Score: -62.27

Stock appears to be at less than fair value at the moment. Not a lot of pipeline and mostly dependent on FDA approval process at this point, but this company is ripe for acquisition if nothing else.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 37 :   1 2 3 4 5 Next »

Wall Street

picks per page. CHANGE

Sorry, no results found.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners